Characteristics of Japanese inflammatory bowel disease susceptibility loci

Journal of Gastroenterology

Volumn 49, Issue 8, 2014, Pages 1217-1230

  Arimura, Yoshiaki ^a   Isshiki, Hiroyuki ^a   Onodera, Kei ^a   Nagaishi, Kanna ^a   Yamashita, Kentaro ^a   Sonoda, Tomoko ^a   Matsumoto, Takayuki ^b   Takahashi, Atsushi ^c   Takazoe, Masakazu ^d   Yamazaki, Keiko ^e   Kubo, Michiaki ^e   Fujimiya, Mineko ^a   Imai, Kohzoh ^f   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c RIKEN   (Japan)

^d Social Insurance Chuo General Hospital   (Japan)

^e RIKEN Center for Integrative Medical Sciences   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Genetic polymorphisms; IBD; Japan; Meta analysis; Susceptibility genes

Indexed keywords

ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CROHN DISEASE; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; HUMAN; JAPAN; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84905699198     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0866-2     Document Type: Article

References (82)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621.
2. Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol. 2006;41:10-6.
3. Kuwahara E, Asakura K, Nishiwaki Y, Inoue N, Watanabe M, Hibi T, et al. Effect of family history on inflammatory bowel disease characteristics in Japanese patients. J Gastroenterol. 2012;47:961-8.
4. Van Limbergen J, Russell RK, Nimmo ER, Satsangi J. The genetics of inflammatory bowel disease. Am J Gastroenterol. 2007;102:2820-31. (Pubitemid 350179337)
5. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007;39:830-2. (Pubitemid 47014496)
6. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, Annese V, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet. 2009;41:216-20.
7. Franke A, Balschun T, Sina C, Ellinghaus D, Häsler R, Mayr G, et al. Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet. 2010;42:292-4.
8. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-24.
9. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603. (Pubitemid 32531408)
10. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007;39:207-11. (Pubitemid 46184351)
11. Steinman L. A brief history of Th17, the first major revision in the Th1/Th2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007;13:139-45.
12. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet. 2001;29:223-8. (Pubitemid 32952663)
13. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL-23R as an inflammatory bowel disease gene. Science. 2006;314:1461-3. (Pubitemid 44871953)
14. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 2002;123:86-91. (Pubitemid 34747528)
15. Yamazaki K, Takazoe M, Tanaka T, Ichimori T, Saito S, Iida A, et al. Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J Hum Genet. 2004;49:664-8.
16. Yamazaki K, Onouchi Y, Takazoe M, Kubo M, Nakamura Y, Hata A. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J Hum Genet. 2007;52:575-83. (Pubitemid 47012531)
17. Yamazaki K, McGovern D, Ragoussis J, Paolucci M, Butler H, Jewell D, et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet. 2005; 14:3499-506. (Pubitemid 41672132)
18. Asano K, Matsushita T, Umeno J, Hosono N, Takahashi A, Kawaguchi T, et al. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet. 2009;41:1325-9.
19. Okada Y, Yamazaki K, Umeno J, Takahashi A, Kumasaka N, Ashikawa K, et al. HLA-Cw&z.ast;1202-B&z.ast;5201-DRB1&z.ast;1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease. Gastroenterology. 2011;141:864-71.
20. Yamazaki K, Umeno J, Takahashi A, Hirano A, Johnson TA, Kumasaka N, et al. A genome-wide association study identifies 2 susceptibility loci for Crohn's disease in a Japanese population. Gastroenterology. 2013;144:781-8.
21. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
22. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-75. (Pubitemid 47330214)
23. Wang Z, Hu J, Fan R, Zhou J, Zhong J. Association between CD14 gene C-260T polymorphism and inflammatory bowel disease: a meta-analysis. PLoS ONE. 2012;7:e45144.
24. Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis. 2008;14:437-45. (Pubitemid 351571823)
25. Tanaka M, Arimura Y, Goto A, Hosokawa M, Nagaishi K, Yamashita K, et al. Genetic variants in surfactant, pulmonary-associated protein D (SFTPD) and Japanese susceptibility to ulcerative colitis. Inflamm Bowel Dis. 2009;15:918-25.
26. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6. (Pubitemid 20015811)
27. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med. 2005;24:1291-306. (Pubitemid 40585169)
28. Breslow NE, Day NE. Statistical methods in cancer research. Volume 1 - the analysis of case-control studies. Lyon, UK International Agency for Research on Cancer. IARC Sci Publ. 1980;32:5-338.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. (Pubitemid 37088507)
30. Weir BS. Genetic data analysis II. Sunderland: Sinauer Associates; 1996.
31. Arai T, Kakuta Y, Kinouchi Y, Kimura T, Negoro K, Aihara H, et al. Increased expression of NKX2.3 mRNA transcribed from the risk haplotype for ulcerative colitis in the involved colonic mucosa. Hum Immunol. 2011;72:587-91.
32. Yamazaki K, Takahashi A, Takazoe M, Kubo M, Onouchi Y, Fujino A, et al. Positive association of genetic variants in the upstream region of NKX2-3 with Crohn's disease in Japanese patients. Gut. 2009;58:228-32.
33. Nakagome S, Takeyama Y, Mano S, Sakisaka S, Matsui T, Kawamura S, et al. Population-specific susceptibility to Crohn's disease and ulcerative colitis; dominant and recessive relative risks in the Japanese population. Ann Hum Genet. 2010;74:126-36.
34. Kakuta Y, Kinouchi Y, Negoro K, Takahashi S, Shimosegawa T. Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease. Gut. 2006;55:1527-8. (Pubitemid 44476808)
35. Prescott NJ, Dominy KM, Kubo M, Lewis CM, Fisher SA, Redon R, et al. Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease. Hum Mol Genet. 2010;19:1828-39.
36. Hayashi R, Tahara T, Shiroeda H, Saito T, Nakamura M, Tsutsumi M, et al. Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis. Clin Exp Med. 2012;. doi:10.1007/s10238-012-0206-5.
37. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol. 2008;28:44-9.
38. Takagawa T, Tamura K, Takeda N, Tomita T, Ohda Y, Fukunaga K, et al. Association between IL-18 gene promoter polymorphisms and inflammatory bowel disease in a Japanese population. Inflamm Bowel Dis. 2005;11:1038-43. (Pubitemid 41682559)
39. Tamura K, Fukuda Y, Sashio H, Takeda N, Bamba H, Kosaka T, et al. IL18 polymorphism is associated with an increased risk of Crohn's disease. J Gastroenterol. 2002;37:111-6. (Pubitemid 35385941)
40. Sashio H, Tamura K, Ito R, Yamamoto Y, Bamba H, Kosaka T, et al. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics. 2002;53:1020-7. (Pubitemid 34275765)
41. Negoro K, Kinouchi Y, Hiwatashi N, Takahashi S, Takagi S, Satoh J, et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology. 1999;117:1062-8. (Pubitemid 29512664)
42. Matsuoka M, Sudo S, Nakamura M, Sugisaka H, Negishi M, Miyakawa Y, et al. Genetic association analysis of TNF-α and CD14 gene polymorphism with inflammatory bowel disease. Jpn J Gastroenterol. 2003;100(Suppl):A711 (in Japanese).
43. Aoyagi Y, Nagata S, Kudo T, Fujii T, Wada M, Chiba Y, et al. Peroxisome proliferator-activated receptor α 2 mutation may cause a subset of ulcerative colitis. Pediatr Int. 2010;52:729-34.
44. Wang F, Tahara T, Arisawa T, Sakata M, Takahama K, Watanabe M, et al. Polymorphism of peroxisome proliferator-activated receptor gamma is not associated to Japanese ulcerative colitis. Hepatogastroenterology. 2008;55:73-5. (Pubitemid 351462166)
45. Sato K, Shiota M, Fukuda S, Iwamoto E, Machida H, Inamine T, et al. Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based biomarker for susceptibility to Crohn's disease in the Japanese population. J Clin Immunol. 2009;29:815-25.
46. Machida H, Tsukamoto K, Wen CY, Narumi Y, Shikuwa S, Isomoto H, et al. Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese. World J Gastroenterol. 2005;11:4188-93. (Pubitemid 41086869)
47. Matsuzawa J, Sugimura K, Matsuda Y, Takazoe M, Ishizuka K, Mochizuki T, et al. Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population. Gut. 2003;52:75-8. (Pubitemid 36020769)
48. Narumi Y, Isomoto H, Shiota M, Sato K, Kondo S, Machida H, et al. Polymorphisms of PTPN11 coding SHP-2 as biomarkers for ulcerative colitis susceptibility in the Japanese population. J Clin Immunol. 2009;29:303-10.
49. Osuga T, Sakaeda T, Nakamura T, Yamada T, Koyama T, Tamura T, et al. MDR1 C3435T polymorphism is predictive of later onset of ulcerative colitis in Japanese. Biol Pharm Bull. 2006;29:324-9. (Pubitemid 43200905)
50. Kosaka T, Yoshino J, Inui K, Wakabayashi T, Okushima K, Kobayashi T, et al. Association between SHMT gene polymorphisms and ulcerative colitis. Jpn J Gastroenterol. 2009;106(Suppl):A826 (in Japanese).
51. Shiroeda H, Tahara T, Nakamura M, Shibata T, Nomura T, Yamada H, et al. Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine. 2010;51:173-7.
52. Nohara H, Okayama N, Inoue N, Koike Y, Fujimura K, Suehiro Y, et al. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol. 2004;39:242-6. (Pubitemid 38519429)
53. Fuse K, Katakura K, Sakamoto N, Ohira H. Toll-like receptor 9 gene mutations and polymorphisms in Japanese ulcerative colitis patients. World J Gastroenterol. 2010;16:5815-21.
54. Wang F, Tahara T, Arisawa T, Shibata T, Nakamura M, Fujita H, et al. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis. J Gastroenterol Hepatol. 2007;22:925-9. (Pubitemid 46911033)
55. Obana N, Takahashi S, Kinouchi Y, Negoro K, Takagi S, Hiwatashi N, et al. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol. 2002;37:699-704. (Pubitemid 34620933)
56. Oomori S. Association between polymorphisms in the inhibitor of Kappa B-like protein (IKBL) gene and ulcerative colitis in a Japanese population. Med J Sendai Red Cross Hosp. 2009;18:23-32 (in Japanese).
57. Aizawa H, Kinouchi Y, Negoro K, Nomura E, Imai G, Takahashi S, et al. HLA-B is the best candidate of susceptibility genes in HLA for Japanese ulcerative colitis. Tissue Antigens. 2009;73:569-74.
58. Kinouchi Y, Matsumoto K, Negoro K, Takagi S, Takahashi S, Hiwatashi N, et al. HLA-B genotype in Japanese patients with Crohn's disease. Dis Colon Rectum. 2003;46:S10-4. (Pubitemid 37266355)
59. Seki SS, Sugimura K, Ota M, Matsuzawa J, Katsuyama Y, Ishizuka K, et al. Stratification analysis of MICA triplet repeat polymorphisms and HLA antigens associated with ulcerative colitis in Japanese. Tissue Antigens. 2001;58:71-6. (Pubitemid 33020619)
60. Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, et al. HLA-DRB1&z.ast;1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci. 1995;40:814-8.
61. Matsumura Y, Kinouchi Y, Nomura E, Negoro K, Kakuta Y, Endo K, et al. HLA-DRB1 alleles influence clinical phenotypes in Japanese patients with ulcerative colitis. Tissue Antigens. 2008;71:447-52. (Pubitemid 351537556)
62. Tremelling M, Berzuini C, Massey D, Bredin F, Price C, Dawson C, et al. Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population. Inflamm Bowel Dis. 2008;14:733-7. (Pubitemid 351898055)
63. Takedatsu H, Michelsen KS, Wei B, Landers CJ, Thomas LS, Dhall D, et al. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology. 2008;135:552-67.
64. Lawrence PA, Morata G. Homeobox genes: their function in Drosophila segmentation and pattern formation. Cell. 1994;78:181-9. (Pubitemid 24241087)
65. Buchberger A, Pabst O, Brand T, Seidl K, Arnold HH. Chick NKx-2.3 represents a novel family member of vertebrate homologues to the Drosophila homeobox gene tinman: differential expression of cNKx-2.3 and cNKx-2.5 during heart and gut development. Mech Dev. 1996;56:151-63. (Pubitemid 26182628)
66. Fu Y, Yan W, Mohun TJ, Evans SM. Vertebrate tinman homologues XNk2-3 and XNk2-5 are required for heart formation in a functionally redundant manner. Development. 1998;125:4439-49. (Pubitemid 28564288)
67. Wang CC, Biben C, Robb L, Nassir F, Barnett L, Davidson NO, et al. Homeodomain factor Nk2-3 controls regional expression of leukocyte homing coreceptor MAdCAM-1 in specialized endothelial cells of the viscera. Dev Biol. 2000;224:152-67. (Pubitemid 30661001)
68. Pabst O, Förster R, Lipp M, Engel H, Arnold HH. NKX2.3 is required for MAdCAM-1 expression and homing of lymphocytes in spleen and mucosa-associated lymphoid tissue. EMBO J. 2000;19:2015-23. (Pubitemid 30237577)
69. Stokkers PC, Reitsma PH, Tytgat GN, van Deventer SJ. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut. 1999;45:395-401. (Pubitemid 29400716)
70. Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex. World J Gastroenterol. 2006;12:3628-35. (Pubitemid 43950938)
71. Yang SK, Hong M, Zhao W, Jung Y, Baek J, Tayebi N, et al. Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut. 2013;. doi:10.1136/gutjnl-2013-305193.
72. Ng SC, Tsoi KK, Kamm MA, Xia B, Wu J, Chan FK, et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis. 2012;6:1164-76.
73. Franke A, Balschun T, Karlsen TH, Hedderich J, May S, Lu T, et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet. 2008;40:713-5. (Pubitemid 351748866)
74. International Inflammatory Bowel Disease Genetics Consortium (IIBDGC). Ulcerative colitis meta-analysis summary statistics. http://www.ibdgenetics.org/ downloads.html.
75. Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet. 2008;4:e1000024.
76. Ahmad T, Armuzzi A, Neville M, Bunce M, Ling KL, et al. The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens. 2003;62:527-35. (Pubitemid 37476000)
77. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, et al. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology. 1997;112:1845-53.
78. Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex. World J Gastroenterol. 2006;12:3628-35. (Pubitemid 43950938)
79. Chervonsky AV. Influence of microbial environment on autoimmunity. Nat Immunol. 2010;11:28-35.
80. Birney E. Chromatin and heritability: how epigenetic studies can complement genetic approaches. Trends Genet. 2011;5:172-6.
81. Liu Y, Aryee MJ, Padyukov L, Fallin MD, Hesselberg E, Runarsson A, et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol. 2013;2:142-7.
82. Ventham NT, Kennedy NA, Nimmo ER, Satsangi J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology. 2013;145:293-308.